OVERVIEW: The JPB Foundation’s disease-related grantmaking focuses on Parkinson’s and diabetes. The foundation has noted that it plans to add more diseases to its grantmaking roster in the future.
IP TAKE: JPB offers sizeable grants to scientists who commit to working within a collaborative framework. Those that prefer to conduct their work in isolation will not find much luck with JPB.
PROFILE: With assets at $2 billion to $3 billion, the New York-based JPB Foundation is a funding powerhouse. The foundation carries on the giving legacy of Jeffry and Barbara Picower and focuses on poverty, medical research, and the environment.
JPB's disease-related grantmaking comes out of its Medical Research program, awarding grants to consortiums of scientists studying Parkinson’s disease and diabetes. The foundation “supports five to eight world-class scientists who agree to conduct their research within a collaborative framework.” While JPB currently backs research into Parkinson’s and diabetes, it says it plans to add more diseases to its funding targets.
Given the exclusivity of JPBs consortiums, it is unsurprising that it handpicks scientists and researchers working at medical and academic institutions such as Beth Israel Deaconess Medical Center, MIT's Picower Institute for Learning and Memory (PILM), and Columbia University.
Grant amounts are substantial, often ranging from $150,000 to $700,000. JPB handpicks grantees taking different approaches to their research and whose work is complementary to that of other grantees. The hope here is that the multi-pronged approaches will lead to discoveries that would not have otherwise occurred if not for the collaborative nature of the consortium.
JPB does not accept unsolicited grant applications or requests for funding.
- Barbara Picower, President
- April Freilich, COO and Senior Vice President